Axerion Therapeutics Sees New Investment
Thursday, April 08, 2010 5:32:00 AM PDT | VentureDeal Staff
New Haven, Connecticut -- Pharmaceutical startup company Axerion Therapeutics (no website) has raised $750,000 in seed financing.
Axerion is a very early stage company focused on neurological diseases including axon regeneration therapy for CNS injuries.
Connecticut Innovations made the investment. The company did not disclose how the funding proceeds would be used.
Email Page | Print Page